Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · IEX Real-Time Price · USD
14.00
+1.05 (8.11%)
At close: Apr 24, 2024, 4:00 PM
14.31
+0.31 (2.21%)
After-hours: Apr 24, 2024, 7:58 PM EDT

Sage Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
86.467.696.311,1146.8790.270000
Upgrade
Revenue Growth (YoY)
1024.84%21.85%-99.43%16123.06%-92.39%-----
Upgrade
Cost of Revenue
2.160.810.550.570.400000
Upgrade
Gross Profit
84.36.875.761,1146.4790.270000
Upgrade
Selling, General & Admin
274.52227.7183.5196.95345.78201.462.8839.4125.299.71
Upgrade
Research & Development
356.24326.16283.17292.71368.82282.11210.28120.7669.3624.1
Upgrade
Other Operating Expenses
33.390027.74000000
Upgrade
Operating Expenses
664.15553.86466.66517.41714.59483.51273.16160.1694.6533.81
Upgrade
Operating Income
-579.85-546.99-460.91596.23-708.12-393.24-273.16-160.16-94.65-33.81
Upgrade
Other Expense / Income
-38.36-14.21-3.02-9.85-27.89-20.36-3.04-1.18-0.160
Upgrade
Pretax Income
-541.49-532.78-457.89606.07-680.24-372.88-270.12-158.99-94.5-33.81
Upgrade
Net Income
-541.49-532.78-457.89606.07-680.24-372.88-270.12-158.99-94.5-33.81
Upgrade
Preferred Dividends
0000000002.29
Upgrade
Net Income Common
-541.49-532.78-457.89606.07-680.24-372.88-270.12-158.99-94.5-36.11
Upgrade
Shares Outstanding (Basic)
60595952514638332822
Upgrade
Shares Outstanding (Diluted)
60595953514638332822
Upgrade
Shares Change
0.89%1.08%10.69%4.27%10.22%21.01%13.80%20.57%28.76%1345.72%
Upgrade
EPS (Basic)
-9.05-8.98-7.8011.66-13.38-8.08-7.09-4.75-3.40-1.67
Upgrade
EPS (Diluted)
-9.05-8.98-7.8011.43-13.38-8.08-7.09-4.75-3.40-1.67
Upgrade
Free Cash Flow
-541.14-460.97-378.55663.94-534.46-263.53-220.64-120.1-70.88-27.17
Upgrade
Free Cash Flow Per Share
-9.04-7.77-6.4512.77-10.51-5.71-5.79-3.59-2.55-1.26
Upgrade
Gross Margin
97.50%89.42%91.23%99.95%94.18%100.00%----
Upgrade
Operating Margin
-670.69%-7116.69%-7306.74%53.51%-10310.48%-435.61%----
Upgrade
Profit Margin
-626.32%-6931.88%-7258.91%54.40%-9904.46%-413.06%----
Upgrade
Free Cash Flow Margin
-625.92%-5997.57%-6001.17%59.59%-7781.84%-291.93%----
Upgrade
EBITDA
-540.1-531.66-453.71608.7-677.96-371.74-269.59-158.71-94.38-33.76
Upgrade
EBITDA Margin
-624.71%-6917.28%-7192.61%54.63%-9871.21%-411.79%----
Upgrade
Depreciation & Amortization
1.391.124.182.632.281.140.530.280.120.05
Upgrade
EBIT
-541.49-532.78-457.89606.07-680.24-372.88-270.12-158.99-94.5-33.81
Upgrade
EBIT Margin
-626.32%-6931.88%-7258.91%54.40%-9904.46%-413.06%----
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).